246 related articles for article (PubMed ID: 11093454)
1. Responsiveness of fibromyalgia clinical trial outcome measures.
Dunkl PR; Taylor AG; McConnell GG; Alfano AP; Conaway MR
J Rheumatol; 2000 Nov; 27(11):2683-91. PubMed ID: 11093454
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
3. Problem elicitation to assess patient priorities in ankylosing spondylitis and fibromyalgia.
Bakker C; van der Linden S; van Santen-Hoeufft M; Bolwijn P; Hidding A
J Rheumatol; 1995 Jul; 22(7):1304-10. PubMed ID: 7562763
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Distler O; Eich W; Dokoupilova E; Dvorak Z; Fleck M; Gaubitz M; Hechler M; Jansen JP; Krause A; Bendszus M; Pache L; Reiter R; Müller-Ladner U
Arthritis Rheum; 2010 Jan; 62(1):291-300. PubMed ID: 20039417
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
Holman AJ; Myers RR
Arthritis Rheum; 2005 Aug; 52(8):2495-505. PubMed ID: 16052595
[TBL] [Abstract][Full Text] [Related]
6. Relationships between the fibromyalgia impact questionnaire, tender point count, and muscle strength in female patients with fibromyalgia: a cohort study.
Henriksen M; Lund H; Christensen R; Jespersen A; Dreyer L; Bennett RM; Danneskiold-Samsøe B; Bliddal H
Arthritis Rheum; 2009 Jun; 61(6):732-9. PubMed ID: 19479709
[TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial comparing fitness and biofeedback training versus basic treatment in patients with fibromyalgia.
van Santen M; Bolwijn P; Verstappen F; Bakker C; Hidding A; Houben H; van der Heijde D; Landewé R; van der Linden S
J Rheumatol; 2002 Mar; 29(3):575-81. PubMed ID: 11908576
[TBL] [Abstract][Full Text] [Related]
8. Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial.
Gür A; Karakoc M; Nas K; Cevik R; Sarac J; Ataoglu S
Rheumatol Int; 2002 Sep; 22(5):188-93. PubMed ID: 12215864
[TBL] [Abstract][Full Text] [Related]
9. Patient utilities in fibromyalgia and the association with other outcome measures.
Bakker C; Rutten M; van Santen-Hoeufft M; Bolwijn P; van Doorslaer E; Bennett K; van der Linden S
J Rheumatol; 1995 Aug; 22(8):1536-43. PubMed ID: 7473480
[TBL] [Abstract][Full Text] [Related]
10. No effect of antiviral (valacyclovir) treatment in fibromyalgia: a double blind, randomized study.
Kendall SA; Schaadt ML; Graff LB; Wittrup I; Malmskov H; Krogsgaard K; Bartels EM; Bliddal H; Danneskiold-Samsøe B
J Rheumatol; 2004 Apr; 31(4):783-4. PubMed ID: 15088307
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine.
Bennett R; Russell IJ; Choy E; Spaeth M; Mease P; Kajdasz D; Walker D; Wang F; Chappell A
Clin Ther; 2012 Apr; 34(4):824-37. PubMed ID: 22421576
[TBL] [Abstract][Full Text] [Related]
12. An open-label study of quetiapine in the treatment of fibromyalgia.
Hidalgo J; Rico-Villademoros F; Calandre EP
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):71-7. PubMed ID: 16889882
[TBL] [Abstract][Full Text] [Related]
13. Assessing functional disability and health status of women with fibromyalgia: validation of a Hebrew version of the Fibromyalgia Impact Questionnaire.
Buskila D; Neumann L
J Rheumatol; 1996 May; 23(5):903-6. PubMed ID: 8724306
[TBL] [Abstract][Full Text] [Related]
14. Assessing responsiveness of generic and specific health related quality of life measures in heart failure.
Eurich DT; Johnson JA; Reid KJ; Spertus JA
Health Qual Life Outcomes; 2006 Nov; 4():89. PubMed ID: 17125512
[TBL] [Abstract][Full Text] [Related]
15. Group treatment of fibromyalgia: a 6 month outpatient program.
Bennett RM; Burckhardt CS; Clark SR; O'Reilly CA; Wiens AN; Campbell SM
J Rheumatol; 1996 Mar; 23(3):521-8. PubMed ID: 8832996
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in women with fibromyalgia syndrome: validation of the QIF, the French version of the fibromyalgia impact questionnaire.
Perrot S; Dumont D; Guillemin F; Pouchot J; Coste J;
J Rheumatol; 2003 May; 30(5):1054-9. PubMed ID: 12734906
[TBL] [Abstract][Full Text] [Related]
17. Electroconvulsive therapy in patients with depression and fibromyalgia.
Huuhka MJ; Haanpää ML; Leinonen EV
Eur J Pain; 2004 Aug; 8(4):371-6. PubMed ID: 15207518
[TBL] [Abstract][Full Text] [Related]
18. What makes patients with fibromyalgia feel better? Correlations between Patient Global Impression of Improvement and changes in clinical symptoms and function: a pooled analysis of 4 randomized placebo-controlled trials of duloxetine.
Hudson JI; Arnold LM; Bradley LA; Choy EH; Mease PJ; Wang F; Ahl J; Wohlreich MM
J Rheumatol; 2009 Nov; 36(11):2517-22. PubMed ID: 19833743
[TBL] [Abstract][Full Text] [Related]
19. A randomized placebo-controlled study of noninvasive cortical electrostimulation in the treatment of fibromyalgia patients.
Hargrove JB; Bennett RM; Simons DG; Smith SJ; Nagpal S; Deering DE
Pain Med; 2012 Jan; 13(1):115-24. PubMed ID: 22233397
[TBL] [Abstract][Full Text] [Related]
20. Low-frequency pulsed electromagnetic field therapy in fibromyalgia: a randomized, double-blind, sham-controlled clinical study.
Sutbeyaz ST; Sezer N; Koseoglu F; Kibar S
Clin J Pain; 2009 Oct; 25(8):722-8. PubMed ID: 19920724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
